SHENGSHI MEDICAL TRAVEL
Regenerative medicine
Understand your options, service scope and next steps for a medical trip to China. Hospital assessment and written arrangements come before booking.
Understand the pathway before you travel
An evolving field deserves clear questions about evidence, regulation and alternatives. We help you identify what is known about a specific project before you make travel or payment decisions.
Medical fees are separate from our travel services. An initial review is not a promise of treatment, results or a fixed discharge date.
Bring the right information
Relevant diagnosis, reports, prior procedures, current medicines, allergies and your main questions. Ask us about the agreed record-transfer process; public upload is not enabled.
Ask about your choices
Ask the clinician about established options, why a proposed approach may fit, its evidence, risks, alternatives and realistic follow-up needs. New cell technologies are not the default answer for cancer or chronic illness.
Plan for continuity
We help organise available hospital records and the agreed translations. With your permission, we can assist with a handover to your doctor at home. Originals and translations are clearly distinguished; certified translations and extra documentation require advance confirmation.
The conversation matters as much as the appointment
Your interpreter helps you ask questions and understand the doctor's explanation. You can ask about the purpose, risks, alternatives and costs. We agree in advance which written summaries and translations can be provided, in which language, when and at what cost.
8 hours of vehicle service + 8 hours of interpreting, every day.
Planned around your confirmed appointments and itinerary. Additional hours, transfer scope and any extra charges are agreed before extending the service.
BOAO LECHENG · 2026
29 reported biomedical projects. Understand the details.
Public reporting in April 2026 stated that 29 advanced biomedical technology projects had been approved in Boao Lecheng. These span cell- and gene-based approaches. Current availability, eligibility and costs must be confirmed with the relevant medical institution.
The entries below follow a published third-party compilation, not an official consolidated approval register. Numbers are reference indexes, not approval numbers. They are not 29 distinct regenerative treatments: immune-cell and gene projects are included, and some indications appear at more than one institution. Listing does not mean a project is currently available, suitable for you or approved in your home country.
These are planning references, not independently verified current hospital tariffs. Each heading identifies the condition discussed, not a diagnosis or eligibility decision. A session, vial, injection or course is not necessarily the whole treatment budget. Assessment, hospital stay, additional medicines, follow-up and travel may cost extra; request an itemised written quotation. Two entries were listed without an amount and remain unpriced here.
Cell-based repair & modulation
19
Umbilical cord MSCs · knee osteoarthritis
Published index · current status requires verification
Ruijin Hospital Hainan
One side only. A bilateral plan requires a separate quotation.
Same indication appears at different institutions in the compilation.
Ask About This TreatmentAirway basal cells · COPD
Published index · current status requires verification
Ruijin Hospital Hainan
Umbilical cord MSCs · heart failure with reduced ejection fraction
Published index · current status requires verification
West China Lecheng Hospital
MSCs · complications after bone marrow transplantation
Published index · current status requires verification
West China Lecheng Hospital
Airway basal cells · interstitial lung disease
Published index · current status requires verification
Ruijin Hospital Hainan
Airway basal cells · bronchiectasis
Published index · current status requires verification
Ruijin Hospital Hainan
Umbilical cord MSCs · premature ovarian insufficiency
Published index · current status requires verification
Ciming Boao International Hospital
Menstrual blood MSCs · pulmonary fibrosis
Published index · current status requires verification
Shulan (Boao) Hospital
VUM02 umbilical cord MSCs · liver cirrhosis
Published index · current status requires verification
Boao Medcell Hospital
The disclosed 2025 approval was conditional on further checks within six months. Completion and current validity have not been verified here.
Ask About This TreatmentUmbilical cord MSCs · rheumatoid arthritis
Published index · current status requires verification
West China Lecheng Hospital
Dental pulp MSCs · periodontal disease
Published index · current status requires verification
Yiling Hospital
Menstrual blood MSCs · decompensated cirrhosis
Published index · current status requires verification
Shulan (Boao) Hospital
Umbilical cord MSCs · type 2 diabetes
Published index · current status requires verification
Ciming Boao International Hospital
Umbilical cord MSCs · knee osteoarthritis
Published index · current status requires verification
Hainan Diwan Hospital
One side only. A bilateral plan requires a separate quotation.
Same indication appears at different institutions in the compilation.
Ask About This TreatmentAllogeneic endothelial progenitor cells · critical limb ischaemia
Published index · current status requires verification
West China Lecheng Hospital
GLP-1 / FGF21-expressing adipose-derived cells · type 2 diabetes
Published index · current status requires verification
Ruijin Hospital Hainan
M-021001 · knee joint injury
Published index · current status requires verification
Boao Super Hospital
One side only. A bilateral plan requires a separate quotation.
iPSC-derived motor neuron precursor cells · ALS
Published index · current status requires verification
Ruijin Hospital Hainan
Allogeneic hepatocytes · cirrhosis
Published index · current status requires verification
Boao Super Hospital
Immune-cell approaches
7
Personalised dendritic cell vaccine · malignant tumours
Published index · current status requires verification
West China Lecheng Hospital
Cell vaccine · Epstein–Barr virus infection
Published index · current status requires verification
West China Lecheng Hospital
Activated T cells · adjuvant care after liver cancer surgery
Published index · current status requires verification
Shulan (Boao) Hospital
Autologous NK cells with immunotherapy · solid tumours
Published index · current status requires verification
West China Lecheng Hospital
The compilation lists 3–6 injections per course; confirm the prescribed number and total.
Autologous dendritic cells · pancreatic and colorectal cancers
Published index · current status requires verification
Boao Super Hospital
Non-gene-modified dendritic cell vaccine · EBV-associated blood cancers
Published index · current status requires verification
Ruijin Hospital Hainan
Autologous NK cells · adjunctive solid tumour care
Published index · current status requires verification
Shulan (Boao) Hospital
Gene-based approaches
3
Gene therapy · inherited retinal disease with biallelic RPE65 mutations
Published index · current status requires verification
Ruijin Hospital Hainan
One side only. A bilateral plan requires a separate quotation.
AAV gene therapy · haemophilia A
Published index · current status requires verification
West China Lecheng Hospital
Gene-edited haematopoietic stem cells · beta thalassaemia
Published index · current status requires verification
Ruijin Hospital Hainan
Explore special-access medicines
What to confirm before considering a project
- Exact technology, institution, indication and written authorisation
- Current implementation status and any outstanding approval conditions
- Clinical evidence, risks, alternatives and follow-up responsibilities
- Assessment, consent, itemised costs and cancellation terms
Institutional information
West China Lecheng Hospital publishes information on its biomedical and cell therapy centre. These disclosures help identify questions to ask; they do not replace a current project-specific assessment.
MSC = mesenchymal stromal/stem cells; iPSC = induced pluripotent stem cells. Classification is an editorial aid; cell and gene approaches can overlap.
YOUR NEXT STEP
Start with a conversation.
Tell us your preferred language, travel dates and the support you need. We will explain the next steps before you book.